Cardiva Medical
Santa Clara, US · Delaware corporation · 7 known investors
Find your way into Cardiva Medical
Sign up to see every warm intro you have to Cardiva Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cardiva Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cardiva Medical, part of Haemonetics, develops the VASCADE family of vascular closure systems, including venous and arterial closure devices used in cardiovascular procedures. It is part of a medical technology company serving hospitals and blood collection centers with blood management, plasma collection, hemostasis analysis, and vascular closure products.
Founders & leadership
Board

Investors · 7
How we know: Essex Woodlands Healthcare Partners's portfolio page · Not right? Tell us
How we know: Evidity Health Capital's portfolio page · Not right? Tell us
How we know: westerntech.com · Not right? Tell us
How we know: funding news · biospace.com · Not right? Tell us
How we know: funding news · biospace.com · Not right? Tell us
Also in the syndicate · 2
Reported raises · per SEC filings
Form D private placements$84.2M disclosed across 2 of 3 rounds · 2017–2020
▶$45MraisedJul 2020 · 25 investors · Other Health CareRule 506(b)
- Matthew CrawfordDirector
- Robert WhiteDirector
- Lisa GarrettExecutive Officer
- Justin BallottaExecutive Officer
- Paul EneverDirector
- Roger OwensExecutive Officer
- John RussellExecutive Officer, Director
- Michael BornitzDirector
- Augustine LienDirector
- Jeryl HillemanDirector
- Thomas BarfieldDirector
- George LeeDirector
- Zia YassinzadehExecutive Officer
- Offering amount
- $45M
- Amount sold
- $45M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$39.2MraisedJan 2018 · 28 investors · Other Health CareRule 506(b)
- Paul EneverDirector
- George LeeDirector
- Lisa GarrettExecutive Officer
- Michael BornitzDirector
- Rick AndersonDirector
- John RussellExecutive Officer, Director
- Augustine LienDirector
- Matthew CrawfordDirector
- Justin BallottaExecutive Officer
- Offering amount
- $49.9M
- Amount sold
- $39.2M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Cardiva Medical do?
- Cardiva Medical, part of Haemonetics, develops the VASCADE family of vascular closure systems, including venous and arterial closure devices used in cardiovascular procedures. It is part of a medical technology company serving hospitals and blood collection centers with blood management, plasma collection, hemostasis analysis, and vascular closure products.
- Who are Cardiva Medical's investors?
- Cardiva Medical's investors include Essex Woodlands Healthcare Partners, Evidity Health Capital, Western Technology Investment, Luther King Capital Management, PTV Healthcare Capital.
- How much funding has Cardiva Medical raised?
- Cardiva Medical has disclosed $84.2M raised across 2 of its 3 known rounds.
- Where is Cardiva Medical headquartered?
- Cardiva Medical is headquartered in Santa Clara, US.
